派林生物：控股股东正在筹划涉及公司控制权变更的事项，股票停牌不超过2个交易日

Core Viewpoint - The company, Pailin Bio (000403), has announced that its controlling shareholder, Qiongcheng Shengbang Yinghao Investment Partnership, is planning a change in the company's control, which is still in the planning stage and has not yet signed any agreements, indicating significant uncertainty [1] Group 1 - The company has received a notification from its controlling shareholder regarding the potential change in control [1] - The matter is still under planning and has not reached the agreement stage, highlighting the uncertainty involved [1] - To ensure fair information disclosure and protect investor interests, the company's stock will be suspended from trading starting June 6, 2025, for a period not exceeding 2 trading days [1] Group 2 - During the suspension period, the company will fulfill its information disclosure obligations and will release relevant announcements once the matter is confirmed [1] - The company will apply for resumption of trading after the relevant matters are determined [1]